- Tous > Medicine Information and Evidence for Policy > Medicines Policy
- Tous > Medicine Information and Evidence for Policy > Monitoring and Evaluation
- Mots-clés > indicators - outcomes, assessment and implementation of pharmaceutical policies
- Mots-clés > monitoring and evaluation
- Mots-clés > national pharmaceutical policy
- Mots-clés > national pharmaceutical sector
- Mots-clés > pharmaceutical master plan
- Mots-clés > policy - priority issues
- Mots-clés > policy implementation
- Mots-clés > situation analysis
- Mots-clés > strategic plan
(2013; 42 pages)
Kunene, K., Fakudze, F., Mndzebele, S., Magagula, F., Shongwe, K. and Vilane, M. 2013. Swaziland Pharmaceutical Strategic Plan (2012–2016): Baseline Survey Report. Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health.
One of the fundamental policy objectives highlighted by the National Health Policy (NHP), 2007 was access to safe medicines and diagnostic technology. In an effort to address this, the Ministry of Health developed the National Pharmaceutical Policy, 2011 (SNPP). The Swaziland Pharmaceutical Strategic Plan, 2012-2016 (SPSP), was developed to operationalize the SNPP. The SPSP provides the overall roadmap for pharmaceutical services development in the health sector. To inform the monitoring and evaluation of the SPSP implementation plan, a baseline survey of the pharmaceutical sector was conducted from July to August 2012.
The SPSP action plan was developed to address gaps identified in the pharmaceutical sector. This baseline survey will serve as an indicator of the level and extent to which the proposed interventions should be implemented in order to adequately address the gaps and strengthen the quality, effectiveness and efficiency of the pharmaceutical services in Swaziland.